Secondary
Arrowhead Research Corp.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.
Symbol
ARWR
Last Closing Price
$5.72
Effective Date
January 18, 2018
Underwriters
Jefferies, Barclays, Cantor Fitzgerald
To view the prospectus for Arrowhead Research Corp., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277